-
公开(公告)号:CA2274247A1
公开(公告)日:1998-08-27
申请号:CA2274247
申请日:1998-02-09
Applicant: BASF AG
Inventor: HOLMAN NICHOLAS JOHN , BALKENHOHL FRIEDHELM , KOSER STEFAN
IPC: C07D487/04 , C12P17/18 , C12P41/00
Abstract: The invention relates to a method for producing enantiomer-free esters of formula (I) (Ia or Ib), where the substituents represent the following: R1 is a hydrogen or a substituted or unsubstituted C1-C6-alkyl-, C1-C6-alkoxy-, or C1-C6-alkanoyl; R2 and R3 independently of each other are hydrogen or a substituted or unsubstituted C1-C6-alkyl-, C1-C6-alkoxy-, or C1-C6-alkanoyl-, C1-C6-alkylthio-, C1-C6-alkyl sulfinyl or C1-C6-alkyl sulfonyl-; R4 is not equal to R5 and independently of each other they are either hydrogen or an substituted or unsubstituted C1-C6-alkyl-, or together with the hydrogen atoms, to which they are bound, form a substituted or unsubstituted C3-C6-cyclo alkylidene; and R6 is a substituted or unsubstituted aryl-, C1-C20-alkyl-, C3-C20-alkenyl-, C3-C20-alkynyl-, C1-C20-alkoxy-C1-C20-alkyl. The method is characterized in that racemic compounds of the formula (II), in which the substituents R1 to R5 have the meanings given above, are reacted with a lipase or esterase in the presence of vinyl esters of formula (III), where R6 has the meaning given above and R7 represents hydrogen or methyl, to form compounds of formula (I).
-
公开(公告)号:BR9607582A
公开(公告)日:1998-07-07
申请号:BR9607582
申请日:1996-02-12
Applicant: BASF AG
Inventor: HOFFKEN HANS WOLFGANG , HORNBERGER WILFRIED , BOHM HANS-JOACHIM , KOSER STEFAN , ZIERKE THOMAS , MACK HELMUT , PFEIFFER THOMAS , SEITZ WERNER
IPC: A61K31/00 , A61K38/55 , A61P7/02 , C07D205/04 , C07D207/16 , C07D213/53 , C07D213/63 , C07D213/72 , C07D213/78 , C07D213/79 , C07D239/28 , C07D241/14 , C07D241/24 , C07D401/12 , C07K5/06 , C07K5/062 , C07K5/078 , A61K31/40 , A61K31/445 , A61K31/495
Abstract: The invention relates to a compound of the formula I: or a salt thereof with a physiologically tolerated acid, or stereoisomers thereof, wherein R 1 , R 2 , A, B, C and D have the meanings described in the specification.
-
公开(公告)号:BR9607412A
公开(公告)日:1998-07-07
申请号:BR9607412
申请日:1996-02-06
Applicant: BASF AG
Inventor: HORNBERGER WILFRIED , PFEIFFER THOMAS , SEITZ WERNER , MACK HELMUT , ZIERKE THOMAS , BOHM HANS-JOACHIM , HOFFKEN HANS WOLFGANG , KOSER STEFAN
Abstract: PCT No. PCT/EP96/00472 Sec. 371 Date Jul. 30, 1997 Sec. 102(e) Date Jul. 30, 1997 PCT Filed Feb. 6, 1996 PCT Pub. No. WO96/24609 PCT Pub. Date Aug. 15, 1996Thrombin inhibitors of the formula where R1, A, B and D have the meaning indicated in the description, and intermediates for the preparation thereof are described. The compounds I are suitable for controlling diseases.
-
公开(公告)号:BG101835A
公开(公告)日:1998-05-29
申请号:BG10183597
申请日:1997-08-15
Applicant: BASF AG
Inventor: BOEHM HANS-JOACHIM , HOEFFKEN HANS W , HORNBERGER WILFRIED , KOSER STEFAN , MACK HELMUT , PFEIFFER THOMAS , SEITZ WERNER , ZIERKE THOMAS
IPC: A61K31/00 , A61K38/55 , A61P7/02 , C07D205/04 , C07D207/16 , C07D213/53 , C07D213/63 , C07D213/72 , C07D213/78 , C07D213/79 , C07D239/28 , C07D241/14 , C07D241/24 , C07D401/12 , C07K5/06 , C07K5/062 , C07K5/078 , A61K31/40 , A61K31/445 , A61K31/495
Abstract: The description relates to compounds of formulain which A, B, D, R' and R have the meanings given in thespecification. the compounds am suitable for the treatment ofdiseases The novel compounds are produced via compounds of theformula H2N-CH2.G-M in which G and M have the meanings given in4 claims
-
公开(公告)号:HUT77289A
公开(公告)日:1998-03-30
申请号:HU9702107
申请日:1995-11-25
Applicant: BASF AG
Inventor: BOEHM HANS-JOACHIM , HORNBERGER WILFRIED , HOEFFKEN HANS WOLFGANG , KOSER STEFAN , MACK HELMUT , PFEIFFER THOMAS , SEITZ WERNER , ZIERKE THOMAS
-
公开(公告)号:NO973657L
公开(公告)日:1997-10-03
申请号:NO973657
申请日:1997-08-08
Applicant: BASF AG
Inventor: SEITZ WERNER , MACK HELMUT , ZIERKE THOMAS , BOEHM HANS-JOACHIM , HOEFFKEN HANS WOLFGANG , KOSER STEFAN , PFEIFFER THOMAS , HORNBERGER WILFRIED
Abstract: PCT No. PCT/EP96/00472 Sec. 371 Date Jul. 30, 1997 Sec. 102(e) Date Jul. 30, 1997 PCT Filed Feb. 6, 1996 PCT Pub. No. WO96/24609 PCT Pub. Date Aug. 15, 1996Thrombin inhibitors of the formula where R1, A, B and D have the meaning indicated in the description, and intermediates for the preparation thereof are described. The compounds I are suitable for controlling diseases.
-
公开(公告)号:NO973657A
公开(公告)日:1997-10-03
申请号:NO973657
申请日:1997-08-08
Applicant: BASF AG
Inventor: SEITZ WERNER , MACK HELMUT , ZIERKE THOMAS , BOEHM HANS-JOACHIM , HOEFFKEN HANS WOLFGANG , KOSER STEFAN , PFEIFFER THOMAS , HORNBERGER WILFRIED
CPC classification number: C07K5/0812 , A61K38/00 , C07K5/06026 , C07K5/06034 , C07K5/0606 , C07K5/06078 , C07K5/06113 , C07K5/06191
-
108.
公开(公告)号:MX9704050A
公开(公告)日:1997-08-30
申请号:MX9704050
申请日:1995-11-25
Applicant: BASF AG
Inventor: BOEHM HANS-JOACHIM , KOSER STEFAN , MACK HELMUT , PFEIFFER THOMAS , SEITZ WERNER , HOFFKEN HANS WOLFGANG , HORNBERGER WILFRIED , ZIERKE THOMAS
IPC: A61K38/00 , A61K38/05 , A61K38/55 , A61P7/02 , C07K5/06 , C07K5/062 , C07K5/065 , C07K5/072 , C07K5/087 , C07K05/06
Abstract: Se describen compuestos de la formula I (Ver Formula) en donde R1; A y B tiene los significados establecidos en la descripcion, así como la preparacion de los mismos. Los compuestos novedosos son adecuados para controlar enfermedades.
-
公开(公告)号:ZA9601276B
公开(公告)日:1997-08-19
申请号:ZA9601276
申请日:1996-02-19
Applicant: BASF AG
Inventor: BOEHM HANS-JOACHIM , HOEFFKEN HANS WOLFGANG , HORNBERGER WILFRIED , KOSER STEFAN , MACK HELMUT , PFEIFFER THOMAS , SEITZ WERNER , ZIERKE THOMAS
IPC: A61K20060101 , C07K20060101 , C12N20060101 , C07K , A61K , C12N
-
公开(公告)号:NO973764D0
公开(公告)日:1997-08-15
申请号:NO973764
申请日:1997-08-15
Applicant: BASF AG
Inventor: BOEHM HANS-JOACHIM , HOEFFKEN HANS WOLFGANG , HORNBERGER WILFRIED , KOSER STEFAN , MACK HELMUT , PFEIFFER THOMAS , SEITZ WERNER , ZIERKE THOMAS
IPC: A61K31/00 , A61K38/55 , A61P7/02 , C07D205/04 , C07D207/16 , C07D213/53 , C07D213/63 , C07D213/72 , C07D213/78 , C07D213/79 , C07D239/28 , C07D241/14 , C07D241/24 , C07D401/12 , C07K5/06 , C07K5/062 , C07K5/078 , C07K
Abstract: The invention relates to a compound of the formula I: or a salt thereof with a physiologically tolerated acid, or stereoisomers thereof, wherein R 1 , R 2 , A, B, C and D have the meanings described in the specification.
-
-
-
-
-
-
-
-
-